Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation

被引：19
|
作者：
St Hilaire, Rose-Claire [1 ,3 ]
Murthy, Subramanyam N. [1 ,2 ,3 ]
Kadowitz, Philip J. [1 ,3 ]
Jeter, James R., Jr. [1 ,3 ]
机构：
[1] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA
[2] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA
[3] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA
来源：
PEPTIDES | 2010年 / 31卷 / 08期
关键词：
Vasoactive intestinal peptide; Proliferation; VPAC1; VPAC2; VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR; PACAP; PHARMACOLOGY; HYPERTENSION; TISSUES; GENE;
D O I：
10.1016/j.peptides.2010.04.024
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Recent studies have suggested the potential use of vasoactive intestinal peptide (VIP) in the treatment of pulmonary arterial hypertension (PAH). An understanding of the mechanism of action of VIP is important for the development of new therapies for PAH. The biological effects of VIP are mediated by two type II guanine nucleotide binding protein (G-protein)-coupled receptors VIP/PACAP (pituitary adenylate cyclase activating peptide) receptor type1 (VPAC1) and VIP/PACAP receptor type 2 (VPAC2). In the present study, the distribution and role of these receptors were investigated and compared in cultured smooth muscle cells from rat aorta and pulmonary artery, as well as in fixed tissue sections of the aorta and pulmonary artery. Western blot analysis, RT-PCR and immunohistochemistry showed the expression of both VIP receptors in tissue sections of the aorta and pulmonary artery as well as in cultured smooth muscle cells from these vessels. The application of a specific antagonist of VPAC1 resulted in a small release from VIP induced inhibition of cell proliferation. In contrast (VIP 6-28: 300 nM) which is an antagonist against both receptors resulted in a significant restoration of proliferation. The expression of cAMP was reduced in the presence of VIP 6-28 and slightly decreased by VPAC1 antagonist. These findings suggest a dual role for VPAC1 and VPAC2 receptors in mediating the antiproliferative effects of VIP with VPAC2 appearing to play a more dominant role. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：1517 / 1522
页数：6
相关论文
共 50 条
  • [21] EFFECT OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND ITS ANALOGUES ON THE SPECIFIC PAC1 AND VPAC1/VPAC2 RECEPTORS ON THE CELL BODIES OF PRIMARY SENSORY NEURONS AND TRANSFECTED CELL LINES
    Szoke, E.
    Saghy, E.
    Payrits, M.
    Reglodi, D.
    Toth, G.
    Couvineau, A.
    Helyes, Z.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 114 - 114
  • [22] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND ITS ANALOGUES ACTIVATE THE SPECIFIC PAC1 AND VPAC1/VPAC2 RECEPTORS ON THE CELL BODIES OF PRIMARY SENSORY NEURONS AND TRANSFECTED CELL LINES
    Saghy, E.
    Szoke, E.
    Banki, E.
    Reglodi, D.
    Toth, G.
    Couvineau, A.
    Helyes, Zs
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S204 - S205
  • [23] Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation
    Hilaire, Rose-Claire St.
    Kadowitz, Philip J.
    Jeter, James R., Jr.
    PEPTIDES, 2009, 30 (12) : 2323 - 2329
  • [24] Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle
    Murthy, Karnam S.
    Mahavadi, Sunila
    Huang, Jiean
    Zhou, Huiping
    Sriwai, Wimolpak
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2008, 294 (02): : C477 - C487
  • [25] Agonist-dependent, PKA-mediated phosphorylation of GRK2 augments homologous desensitization of VPAC2 receptors in smooth muscle
    Zhou, HP
    Grider, JR
    Murthy, KS
    GASTROENTEROLOGY, 2002, 122 (04) : A136 - A136
  • [26] Adenoviral transfer of VIP gene to rat aortic and pulmonary artery smooth muscle cells
    St. Hilaire, Rose-Claire
    Kadowitz, Philip J.
    Jeter, James R., Jr.
    FASEB JOURNAL, 2007, 21 (05): : A420 - A420
  • [27] Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension
    Zurlo, Giada
    Piquereau, Jerome
    Moulin, Maryline
    Da Silva, Julie Pires
    Gressette, Melanie
    Ranchoux, Benoit
    Garnier, Anne
    Ventura-Clapier, Renee
    Fadel, Elie
    Humbert, Marc
    Lemaire, Christophe
    Perros, Frederic
    Veksler, Vladimir
    JOURNAL OF HYPERTENSION, 2018, 36 (05) : 1164 - 1177
  • [28] Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2)
    Anderson, CMH
    Mendoza, ME
    Kennedy, DJ
    Raldua, D
    Thwaites, DT
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) : 564 - 573
  • [29] Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation
    Penumatsa, Krishna C.
    Toksoz, Deniz
    Warburton, Rod R.
    Hilmer, Andrew J.
    Liu, Tiegang
    Khosla, Chaitan
    Comhair, Suzy A. A.
    Fanburg, Barry L.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 307 (07) : L576 - L585
  • [30] Role of calcium in human pulmonary artery smooth muscle cell proliferation.
    Bailey, CL
    McDaniel, SS
    Rubin, LJ
    Yuan, JXJ
    FASEB JOURNAL, 2000, 14 (04): : A578 - A578
12345